FORWARD FEATURES CALENDAR

Allocations

Pan-African private equity firm Development Partners International (DPI), through its third fund ADP III, has made a USD56 million investment in Tunisian tomato processing and agri-business, SICAM.Established in 1969, SICAM is a leading producer of canned tomatoes, pepper pastes, and jams and one of the most recognised brand names in Tunisia’s food and agri-industry, with a strong track record of delivering quality products to its customers. Wholly owned by the Bayahi Group, a leading Tunisian conglomerate, SICAM has quickly become the fastest growing player and market leader of the sauces and condiments segment in Tunisia, in part driven by its
Healthcare technology
While the US healthcare industry has historically been stable throughout economic cycles, it has a large consumer retail component to it, and “foot traffic” has been meaningfully reduced as a result of the coronavirus.  As such, many sectors within healthcare have been materially impacted.  The more discretionary the service, the more the sector has been hit – with some sectors down over 80 per cent. This trend has been mitigated somewhat by the growth in some sectors like telehealth, but overall, healthcare volumes are down substantially. There are signs over the past two weeks though, that volumes have been creeping
Person on a beach
By Audrey Nangle, director of private equity & real assets at MUFG Investor Services – What happens when you take a part of the investment industry that was already changing and subject it to a profound shock? That’s the question that will challenge private markets for the foreseeable future. The landscape was already in flux when the novel coronavirus came onto the scene. Now, some funds are experiencing or anticipating major financial disruption, while others are finding unexpected gains and opportunities.  Even before the coronavirus outbreak, there were numerous drivers in motion. The playing field had become more competitive and
Amsterdam
Amsterdam-based Committed Capital has raised EUR55 million in two months for its third investment vehicle from entrepreneurs, family offices and institutional investors, both in and beyond the Netherlands. The fund, which closed in January, was oversubscribed, while a large part of the subscriptions came from existing investors in the previous fund, said the PE firm.  With the new fund Committed Capital will continue to focus on substantial stakes in Dutch SMEs with an EBITDA between EUR1 million and EUR5 million, as well as a clear ambition to at least double the EBITDA over the participation period, whether or not through
Benson Oak Capital’s private equity arm and co-investors have sold 100 per cent of their stake in Klikpojisteni.cz (Klik) to a company majority owned  by TA Associates, a global growth private equity firm, and minority owned by MCI EuroVentures, a technology investment fund.Klik operates a leading online insurance brokerage in the Czech Republic and Slovakia under domain names Klik.cz and Klik.sk, with offices in Prague, Usti nad Labem and Bratislava. It offers clients the ability to transparently compare prices for non-life and life insurance products, including MTPL, CASCO, home, travel and term life insurance. The company will continue to operate
Eos Venture Partners (Eos) has closed its Strategic InsurTech Fund, which invests in global InsurTech companies.Eos believes the current Covid 19 crisis is acting as a catalyst for change and is expected to supercharge innovation activity. Digital engagement, agility, flexible usage based products, tailored pricing and remote claims assessment are now critical to remain relevant and deliver on the customer promise. Customer expectations, working patterns and awareness of risk have fundamentally changed, forcing the industry to respond.  Strategic Limited Partners in the fund comprise of insurers and reinsurers from the UK, Europe, US, Canada and Asia and include leading players
Trickle of water from a hose
Deal flow will remain depressed until the UK lockdown eases, according to the UK & Ireland Private Capital Breakdown, which covers Covid-19’s impact on the private equity industry. One of the key findings of the latest report is that until we see substantial easing in the UK & Ireland lockdown deal flow will remain depressed as GPs do not plan on closing investments through an entirely virtual process. Most managers will close deals only once they have met management teams face to face and they’ve seen the business operating in full motion. Another trend is that the IT space will
CapStone Holdings has launched GameAbove Capital, a USD50 million private venture fund focused on minority – and women – operated businesses engaged in sustainability-related products and services. GameAbove Capital looks to deploy capital with thoughtful acquisitions, joint ventures, and equity financing in successful expansion-staged entrepreneurial ventures. Investment targets include, but are not limited to, products and services related to sustainability in mobility, learning and workforce development, and protecting clean water. CapStone Holdings is launching the fund now in part to provide further stability for companies during these uncertain times due to the impacts of the coronavirus and to add further
By A Paris – Starting the year with record levels of cash, the private equity industry was, arguably, in a favourable position to weather the storm caused by the Covid-19 pandemic which threw the world into chaos in March 2020. Due to its inherent long-term characteristics and patient capital, private equity is arguably better placed than other sectors to weather the pandemic. But despite this, all areas are being impacted in one way or the other, from valuations and fundraising to cashflow and operational threats, private equity managers are run off their feet, trying to keep up and adapt in an
Medical lab
Omnes has invested EUR60 million in a primary LBO, carried out as a proprietary deal with the Biofutur group, a cluster of medical biology analysis laboratories in Ile-de-France, which is managed by independent medical biologists.

Events

12 November, 2026 – 8:00 am

Directory Listings